Bruce Woda to Lymphoproliferative Disorders
This is a "connection" page, showing publications Bruce Woda has written about Lymphoproliferative Disorders.
Connection Strength
0.386
-
Woda BA, Sullivan JL. Reactive histiocytic disorders. Am J Clin Pathol. 1993 Apr; 99(4):459-63.
Score: 0.105
-
Jagadeesh D, Woda BA, Draper J, Evens AM. Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations. Curr Treat Options Oncol. 2012 Mar; 13(1):122-36.
Score: 0.097
-
Sullivan JL, Woda BA. X-linked lymphoproliferative syndrome. Immunodefic Rev. 1989; 1(4):325-47.
Score: 0.078
-
Wagar EJ, Cromwell MA, Shultz LD, Woda BA, Sullivan JL, Hesselton RM, Greiner DL. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice. J Immunol. 2000 Jul 01; 165(1):518-27.
Score: 0.043
-
Knecht H, Rapha?l M, McQuain C, Rothenberger S, Pihan G, Camilleri-Bro?t S, Bachmann E, Kershaw GR, Ryan S, Kittler EL, Quesenberry PJ, Schlaifer D, Woda BA, Brousset P. Deletion variants within the NF-kappa B activation domain of the LMP1 oncogene prevail in acquired immunodeficiency syndrome-related large cell lymphomas and human immunodeficiency virus-negative atypical lymphoproliferations. Blood. 1996 Feb 01; 87(3):876-81.
Score: 0.032
-
Razvi ES, Jiang Z, Woda BA, Welsh RM. Lymphocyte apoptosis during the silencing of the immune response to acute viral infections in normal, lpr, and Bcl-2-transgenic mice. Am J Pathol. 1995 Jul; 147(1):79-91.
Score: 0.031